Results 71 to 80 of about 22,154 (275)
This case illustrates features of ground glass changes on radiology in a patient who was immunosuppressed with biologics. Microbiology confirmed infection with Bordetella bronchiseptica, highlighting the importance of looking for atypical infections in patients receiving biologics and the importance of pet ownership history.
Debashree Banerjee +5 more
wiley +1 more source
Thymectomy for myasthenia gravis [PDF]
SummaryThe pathophysiological role of the thymus in myasthenia gravis, and the mechanism of therapeutic effect of thymectomy, are incompletely understood. Nevertheless, thymectomy is a valuable treatment modality in selected patients with generalised myasthenia gravis.
J D, Urschel, R P, Grewal
openaire +2 more sources
Neoadjuvant glucocorticoids facilitated less invasive and more complete resection of advanced B‐type thymomas, leading to reduced operative morbidity and improved progression‐free survival compared to upfront surgery. This study supports a novel downstaging strategy for this challenging disease.
Zhen Yu +7 more
wiley +1 more source
Myasthenia. Surgical treatment and its effectiveness
The article reviews the problems of diagnostics and. treatment of myasthenia. The authors consider that thymectomy in modern conditions is founded, expedient and. safe for the patients surgery at the treatment of different forms of myasthenia.
M. B. Skvortsov, A. I. Smolin
doaj
Thymic hyperplasia as a rare etiology of pure red cell aplasia: A case report [PDF]
Introduction. Thymic hyperplasia is a rare condition caused by an increase in cellular thymic mass and, in some cases, is associated with autoimmune diseases, such as pure red cell aplasia (PRCA).
Arsenović Isidora +6 more
doaj +1 more source
Thymectomy for treatment of anti-NMDA receptor encephalitis [PDF]
Benjamin A. Palleiko +3 more
openalex +1 more source
Thymectomy for myasthenia gravis [PDF]
Between 1951 and 1971 thymectomy was performed on 41 patients with myasthenia gravis. They were selected from a total group of 95 myasthenic patients receiving anticholinesterase therapy. The criteria for selecting patients for thymectomy and the assessment of their progress after operation are described.
F R, Edwards, A, Wilson
openaire +2 more sources
Relationship between immune reactivity and developement of thymic lymphoma by N,N'-dimethylnitrosourea in C3Hf-Bi mice [PDF]
By subcutaneous inoculation of N, N'-dimethylnitrosourea to adult male C3Hf/Bi mice once a week for 10 consecutive weeks the authors studied the correlation between immunological functions and histological changes in lymphatic tissues at the latent ...
Motoi, Makoto +2 more
core +1 more source
Minimally Invasive Thymectomy Could Be Attempted for Locally Advanced Thymic Malignancies: A Real-World Study With Propensity Score-Matched Analysis [PDF]
Jun Nakajima
openalex +1 more source
Background Ravulizumab represents the inaugural long‐acting complement C5 inhibitor that has received approval in various countries around the globe for individuals diagnosed with generalized myasthenia gravis (gMG) who are positive for anti‐acetylcholine receptor antibodies.
Yakun Wang +5 more
wiley +1 more source

